Douglas, Australia Clinical Trials

A listing of Douglas, Australia clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

This trial will study ladiratuzumab vedotin (LV) to find out if it works to treat different types of solid tumors. It will also find out what side effects may occur. A side effect is anything the drug does besides treating cancer.

cancer
growth factor
erbb2
chemoradiotherapy
solid tumors
St Vincents Hospital Sydney
 (1037.7 away) Contact site
  • 12 views
  • 28 Oct, 2020
  • +42 other locations
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

This study is designed to assess the safety and efficacy of lenvatinib in combination with pembrolizumab versus standard of care (SOC) chemotherapy, and to also assess the safety and efficacy of lenvatinib monotherapy in participants with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) that have progressed after platinum …

squamous cell carcinoma
metastatic head and neck squamous cell carcinoma
mk-3475
pembrolizumab
carcinoma
Greenslopes Private Hospital ( Site 0105)
 (689.4 away) Contact site
  • 0 views
  • 25 Nov, 2020
  • +25 other locations
Fibrinogen Early In Severe Trauma studY Junior

Haemorrhage in severe trauma is a significant cause of mortality and is potentially the most preventable cause of death in paediatric trauma patients Trauma Induced Coagulopathy (TIC) is a complex coagulopathy associated with severe trauma Hypo/dysfibrinogenaemia plays an important role in TIC Early replacement of fibrinogen may improve outcomes Fibrinogen …

coagulopathy
traumatic hemorrhage
viral inactivation
cryoprecipitate
blood transfusion
Townsville Hospital
 (5.8 away) Contact site
  • 129 views
  • 05 Jul, 2020
  • +9 other locations
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma

The I-MAT trial is a phase II randomised and placebo-controlled trial for patients with stage I-III Merkel cell carcinoma (MCC) to explore efficacy and tolerability of avelumab as adjuvant immunotherapy.

positron emission tomography
carcinoma
18f-fdg
ct scan
immunomodulator
Townsville Hospital
 (5.8 away) Contact site
  • 0 views
  • 26 Nov, 2020
  • +12 other locations